Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEAM-PsA: Etanercept and Methotrexate in Psoriatic Arthritis
NCT02376790Phase 3Completed
- Sponsor
- Amgen
- Start
- Mar 2015
- Primary completion
- Jan 2018
- Modality
- Fc-Fusion Proteins
- Countries
- 18
01
Overview
A Phase 3 trial of etanercept in psoriatic arthritis (PsA), sponsored by Amgen. Started Mar 2015; status: completed.
02
Drugs
etanercept
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT02376790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02376790.